BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34602566)

  • 21. Process of immunogenic cell death caused by disulfiram as the anti-colorectal cancer candidate.
    You SY; Rui W; Chen ST; Chen HC; Liu XW; Huang J; Chen HY
    Biochem Biophys Res Commun; 2019 Jun; 513(4):891-897. PubMed ID: 31003768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced Tumor-Specific Disulfiram Chemotherapy by
    Wu W; Yu L; Jiang Q; Huo M; Lin H; Wang L; Chen Y; Shi J
    J Am Chem Soc; 2019 Jul; 141(29):11531-11539. PubMed ID: 31251050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disulfiram anti-cancer efficacy without copper overload is enhanced by extracellular H2O2 generation: antagonism by tetrathiomolybdate.
    Calderon-Aparicio A; Strasberg-Rieber M; Rieber M
    Oncotarget; 2015 Oct; 6(30):29771-81. PubMed ID: 26356671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diallyl trisulfide induces osteosarcoma cell apoptosis through reactive oxygen species-mediated downregulation of the PI3K/Akt pathway.
    Wang H; Sun N; Li X; Li K; Tian J; Li J
    Oncol Rep; 2016 Jun; 35(6):3648-58. PubMed ID: 27035545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer Pro-oxidant Therapy Through Copper Redox Cycling:
    Rieber M
    Curr Pharm Des; 2020; 26(35):4461-4466. PubMed ID: 32600223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of lung adenocarcinoma by combinations of sulfasalazine (SAS) and disulfiram-copper (DSF-Cu) in cell line models and mice.
    Bagherpoor AJ; Shameem M; Luo X; Seelig D; Kassie F
    Carcinogenesis; 2023 Jun; 44(4):291-303. PubMed ID: 37053033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Copper-Enriched Prussian Blue Nanomedicine for In Situ Disulfiram Toxification and Photothermal Antitumor Amplification.
    Wu W; Yu L; Pu Y; Yao H; Chen Y; Shi J
    Adv Mater; 2020 Apr; 32(17):e2000542. PubMed ID: 32162734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Licochalcone A-Induced Apoptosis Through the Activation of p38MAPK Pathway Mediated Mitochondrial Pathways of Apoptosis in Human Osteosarcoma Cells In Vitro and In Vivo.
    Lin RC; Yang SF; Chiou HL; Hsieh SC; Wen SH; Lu KH; Hsieh YH
    Cells; 2019 Nov; 8(11):. PubMed ID: 31739642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disulfiram induces apoptosis in human melanoma cells: a redox-related process.
    Cen D; Gonzalez RI; Buckmeier JA; Kahlon RS; Tohidian NB; Meyskens FL
    Mol Cancer Ther; 2002 Jan; 1(3):197-204. PubMed ID: 12467214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fructose-coated Angstrom silver inhibits osteosarcoma growth and metastasis via promoting ROS-dependent apoptosis through the alteration of glucose metabolism by inhibiting PDK.
    Hu XK; Rao SS; Tan YJ; Yin H; Luo MJ; Wang ZX; Zhou JH; Hong CG; Luo ZW; Du W; Wu B; Yan ZQ; He ZH; Liu ZZ; Cao J; Wang Y; Situ WY; Liu HM; Huang J; Wang YY; Xia K; Qian YX; Zhang Y; Yue T; Liu YW; Zhang HQ; Tang SY; Chen CY; Xie H
    Theranostics; 2020; 10(17):7710-7729. PubMed ID: 32685015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting cancer stem cells by disulfiram and copper sensitizes radioresistant chondrosarcoma to radiation.
    Wang K; Michelakos T; Wang B; Shang Z; DeLeo AB; Duan Z; Hornicek FJ; Schwab JH; Wang X
    Cancer Lett; 2021 May; 505():37-48. PubMed ID: 33582212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apoptosis and autophagy induced by pyropheophorbide-α methyl ester-mediated photodynamic therapy in human osteosarcoma MG-63 cells.
    Huang Q; Ou YS; Tao Y; Yin H; Tu PH
    Apoptosis; 2016 Jun; 21(6):749-60. PubMed ID: 27108344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting ALDH1A1 by disulfiram/copper complex inhibits non-small cell lung cancer recurrence driven by ALDH-positive cancer stem cells.
    Liu X; Wang L; Cui W; Yuan X; Lin L; Cao Q; Wang N; Li Y; Guo W; Zhang X; Wu C; Yang J
    Oncotarget; 2016 Sep; 7(36):58516-58530. PubMed ID: 27542268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two clinical drugs deubiquitinase inhibitor auranofin and aldehyde dehydrogenase inhibitor disulfiram trigger synergistic anti-tumor effects in vitro and in vivo.
    Huang H; Liao Y; Liu N; Hua X; Cai J; Yang C; Long H; Zhao C; Chen X; Lan X; Zang D; Wu J; Li X; Shi X; Wang X; Liu J
    Oncotarget; 2016 Jan; 7(3):2796-808. PubMed ID: 26625200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intestinal microbiota regulates anti-tumor effect of disulfiram combined with Cu
    Hu H; Cui L; Lu J; Wei K; Wei J; Li S; Zou C; Chen T
    Cancer Med; 2020 Sep; 9(18):6791-6801. PubMed ID: 32750218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disulfiram eradicates tumor-initiating hepatocellular carcinoma cells in ROS-p38 MAPK pathway-dependent and -independent manners.
    Chiba T; Suzuki E; Yuki K; Zen Y; Oshima M; Miyagi S; Saraya A; Koide S; Motoyama T; Ogasawara S; Ooka Y; Tawada A; Nakatsura T; Hayashi T; Yamashita T; Kaneko S; Miyazaki M; Iwama A; Yokosuka O
    PLoS One; 2014; 9(1):e84807. PubMed ID: 24454751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disulfiram/copper induces antitumor activity against gastric cancer cells in vitro and in vivo by inhibiting S6K1 and c-Myc.
    Du C; Guan X; Liu Y; Xu Z; Du X; Li B; Wang M; Zheng Z
    Cancer Chemother Pharmacol; 2022 Apr; 89(4):451-458. PubMed ID: 35201421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disulfiram, an old drug with new potential therapeutic uses for human hematological malignancies.
    Conticello C; Martinetti D; Adamo L; Buccheri S; Giuffrida R; Parrinello N; Lombardo L; Anastasi G; Amato G; Cavalli M; Chiarenza A; De Maria R; Giustolisi R; Gulisano M; Di Raimondo F
    Int J Cancer; 2012 Nov; 131(9):2197-203. PubMed ID: 22322883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disulfiram (DSF) acts as a copper ionophore to induce copper-dependent oxidative stress and mediate anti-tumor efficacy in inflammatory breast cancer.
    Allensworth JL; Evans MK; Bertucci F; Aldrich AJ; Festa RA; Finetti P; Ueno NT; Safi R; McDonnell DP; Thiele DJ; Van Laere S; Devi GR
    Mol Oncol; 2015 Jun; 9(6):1155-68. PubMed ID: 25769405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory effect on ovarian cancer ALDH+ stem-like cells by Disulfiram and Copper treatment through ALDH and ROS modulation.
    Guo F; Yang Z; Kulbe H; Albers AE; Sehouli J; Kaufmann AM
    Biomed Pharmacother; 2019 Oct; 118():109371. PubMed ID: 31545281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.